Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $39.4600 (-2.95%) ($39.4600 - $39.4600) on Sun. Apr. 11, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.07% (three month average) | RSI | 40 | Latest Price | $39.4600(-2.95%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -1.6% a day on average for past five trading days. | Weekly Trend | EDIT declines -3.5% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) (0%) (0%) (0%) (0%) (0%) | Factors Impacting EDIT price | EDIT will decline at least -2.535% in a week (0% probabilities). (0%) (0%) (0%) (0%) (0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.535% (StdDev 5.07%) | Hourly BBV | 0 () | Intraday Trend | 0% | | | |
|
Resistance Level | $43.02 | 5 Day Moving Average | $41.22(-4.27%) | 10 Day Moving Average | $41.14(-4.08%) | 20 Day Moving Average | $43.02(-8.28%) | To recent high | -48.7% | To recent low | 0% | Market Cap | $N/A | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |